Altria is a top choice for building passive income with stable cash flows, despite potential tech stock valuation slowdowns. Learn more about MO stock here.

Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming administration will offer support.

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a look at where Altria Group, Inc. (NYSE:MO) stands against the other high-yield dividend stocks.

Altria Group Inc. (NYSE: MO) is rewarding its shareholders once again with a quarterly dividend of $1.02, payable on Friday, Jan. 10. That is the same as in the prior payout. The company admitted recently that one its most high-profile brands has seen waning demand,

The Biden White House is expected to formally propose a plan ordering cigarette nicotine levels to be reduced dramatically.

Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.

Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and adaptability

“The data show that these nicotine pouch products meet that bar ... similar products from other tobacco competitors, including Altria’s On pouches.

Shares of Altria Group, Inc. (NYSE:MO – Get Free Report) have received an average recommendation of “Hold” from the eight research firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation,

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn can help adult smokers cut back or quit cigarettes.

“The data show that these nicotine pouch products meet that bar ... similar products from other tobacco competitors, including Altria’s On pouches.

U.S. regulators are proposing to cap the amount of nicotine in cigarettes at non-addictive levels, in a potential world-first that could curb smoking and hit tobacco industry earnings.